Market Currents
Belgian drug developer Galapagos signs a deal worth up to $1.35B with Abbott Laboratories (ABT)...
-
Wednesday, February 29, 2012, 5:07 AM ETBelgian drug developer Galapagos signs a deal worth up to $1.35B with Abbott Laboratories (ABT) for the development and production of an oral drug to treat arthritis and other auto-immune diseases. (PR)
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
